4US-21258-25981
1 vaccination
2 coded responses
16 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 341 / FL
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-14
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: GoodFree text: Slight sore throat, very mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-16
- 2021-04-19
- 2021-04-24
- 2021-05-02
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-07-12
- 2021-10-09
-
2022-04-10
Survey response — 12 months, dose 1MedDRA: Tinnitus — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have had chronic tinnitus starting two weeks after my vaccination. I did not originally attribute it to the vaccine since it wasn't listed as a side effect, but I have had chronic tinnitus that is not associated with hearing loss.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-10
Report sent to call center — 12 months, dose 1Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-22
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-10 | Successful 2022-04-22 |
Completed over the phone |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Slight sore throat, very mild
Release 11 — 12 months, dose 1
Symptoms: I have had chronic tinnitus starting two weeks after my vaccination. I did not originally attribute it to the vaccine since it wasn't listed as a side effect, but I have had chronic tinnitus that is not associated with hearing loss.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Tinnitus | · | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release